Michael R Bristow Net Worth & Insider Trades
Michael R Bristow - President and CEO, Arca Biopharma, Inc
What is Michael R Bristow's Net Worth?
The current estimated net worth of Arca Biopharma, Inc's President and CEO, Michael R Bristow, is estimated to be about $52.52K . Michael R Bristow owns about 1,349,361 units of Arca Biopharma, Inc common stock. In the last year at Arca Biopharma, Inc, Michael R Bristow has sold an estimated value of $0 worth.
What is Michael R Bristow's Past Insider Trading?
Michael R Bristow's largest purchase order was 1,069,290 units , worth over $500K on January 28, 2013. In total, Michael R Bristow has made about 5 transactions over a year of their time at Arca Biopharma, Inc. Michael R Bristow usually trades in June, with the busiest year in 2013.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
MICHAEL BRISTOW
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What was Michael R Bristow's Salary in 2020?
As President and CEO of Arca Biopharma, Inc, Michael R Bristow has a total base salary of $286,083 . Michael R Bristow received compensation valued at about $1,061,587 in 2020 after becoming President and CEO. The vast majority of their compensation came in the form of option awards of $619,976 , other earnings, plans or compensations of $144,000 , and other compensation of $11,528 .
Arca Biopharma, Inc Executive Compensation
Name |
Year
|
Salary
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|
| Michael R. Bristow | 2020 | $286,083 | $619,976 | $144,000 | $11,528 | $1,061,587 |
| Michael R. Bristow | 2019 | $284,328 | - | - | $11,823 | $296,151 |
| Thomas A. Keuer | 2020 | $284,937 | $228,412 | $98,000 | $19,675 | $631,024 |
| Thomas A. Keuer | 2019 | $283,189 | - | - | $20,833 | $304,022 |
| Christopher D. Ozeroff | 2020 | $279,617 | $179,467 | $84,000 | $12,764 | $555,848 |
| Christopher D. Ozeroff | 2019 | $277,901 | - | - | $12,256 | $290,157 |
| No matching records found | ||||||
Source: https://www.sec.gov/Archives/edgar/data/907654/000156459021019817/abio-def14a_20210610.htm
What are Arca Biopharma, Inc's Past Insider Trades?
Arca Biopharma, Inc's most recent insider trade came on May 25, 2022 by Funicular Fund Lp and Jacob Maweaver who bought 85,262 units worth $197.4K . In the last 13 years, insiders at Arca Biopharma, Inc have sold an estimated value of $15.26M and bought an estimated value of $9.11M worth of shares. Insider trading is most common in February, with the busiest year in 2022. The most active traders at the company are Michael Bristow, Pres. & Chief Executive Offic, David Christopher Ozeroff, S.V.P., and Robert Conway, Director .
ARCA biopharma, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||